Faith Alese Anderson

Ms. Faith Alese Anderson

Division of Continuing Education, Harvard University, Cambridge, Maryland, USA
orcid

Research Focus & Metrics

Representative Publications

View All Publications
6 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Faith Alese AndersonFaith Alese Anderson
Faith Alese Anderson
TTTracey Tokuhama-Espinosa
Tracey Tokuhama-Espinosa
Background: Bipolar disorder (BD) is a highly heritable and clinically heterogeneous psychiatric condition whose expression reflects interactions among polygenic liability, illness course, treatment, physical health, and environmental context. Epigenetic mechanisms—including DNA methylation, histone modification, chromatin regulation, and non-coding RNAs—are relevant to gene regulation in BD, but current human evidence does not establish that treatment-associated epigenetic changes are biologically transmitted to offspring. Objectives: This transdisciplinary narrative review examines whether longitudinal pharmacological and psychosocial treatment influences epigenetic processes within individuals with BD and considers the implications of these treatment-associated processes for intergenerational risk and resilience. Methods: A targeted, iterative search of HOLLIS, Google Scholar, and PubMed/MEDLINE prioritized peer-reviewed publications from January 2020 through August 2026, supplemented by backward and selective forward citation searching and foundational earlier studies. Results: Pharmacological treatments, including lithium and valproate, influence molecular and gene-regulatory pathways, although BD-specific longitudinal epigenetic evidence remains preliminary and heterogeneous. Psychological interventions have established clinical and functional benefits, but direct evidence of durable epigenetic modification in BD remains insufficient. Overall, treatment-associated biological and contextual modulation within individuals is better supported than germline epigenetic transmission. Conclusions: Future prospective, repeated-measures, parent–offspring, and multigenerational studies are needed to distinguish treatment effects from inherited genetic liability, illness state, prenatal exposure, shared environment, caregiving, and true transgenerational inheritance.